CROSSROADS STRATEGIES, LLC for MERCK & CO., INC.
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; Drug Pricing; Inflation Reduction Act of 2022 (P.L.117-169) implementation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN GREEN | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| CHERYL LYNN JAEGER | — |
| MATHEW LAPINSKI | — |
| JASON BENJAMIN VAN PELT | — |
| STEPHEN THOMAS VOLJAVEC New | Legislative Director, Rep. Vern Buchanan; Legislative Assistant, Senator Marsha Blackburn |
Taxation/Internal Revenue Code TAX
Issues related to tax reform; R&D tax credit; international taxation; Inflation Reduction Act of 2022 (P.L.117-169) implementation; H.R.1, One Big Beautiful Bill Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN GREEN | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| CHERYL LYNN JAEGER | — |
| MATHEW LAPINSKI | — |
| JASON BENJAMIN VAN PELT | — |
| STEPHEN THOMAS VOLJAVEC New | Legislative Director, Rep. Vern Buchanan; Legislative Assistant, Senator Marsha Blackburn |
Trade (domestic/foreign) TRD
Issues related to pharmaceutical IP, supply chain, and tariffs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN GREEN | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| CHERYL LYNN JAEGER | — |
| MATHEW LAPINSKI | — |
| JASON BENJAMIN VAN PELT | — |
| STEPHEN THOMAS VOLJAVEC New | Legislative Director, Rep. Vern Buchanan; Legislative Assistant, Senator Marsha Blackburn |
Budget/Appropriations BUD
H.R.1, One Big Beautiful Bill Act, all bio-pharmaceutical related provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN GREEN | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| CHERYL LYNN JAEGER | — |
| MATHEW LAPINSKI | — |
| JASON BENJAMIN VAN PELT | — |
| STEPHEN THOMAS VOLJAVEC New | Legislative Director, Rep. Vern Buchanan; Legislative Assistant, Senator Marsha Blackburn |
Copyright/Patent/Trademark CPT
Biopharmaceutical innovation and patent policy issues. Bayh-Dole march-in rights policy issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN GREEN | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| CHERYL LYNN JAEGER | — |
| MATHEW LAPINSKI | — |
| JASON BENJAMIN VAN PELT | — |
| STEPHEN THOMAS VOLJAVEC New | Legislative Director, Rep. Vern Buchanan; Legislative Assistant, Senator Marsha Blackburn |
Health Issues HCR
Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, TRICARE Pharmacy Program (FY2026 National Defense Authorization Act), antimicrobial resistance, VICP Program, and PBM reform; Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization; Inflation Reduction Act of 2022 (P.L.117-169) implementation; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN GREEN | — |
| BRITTANY JOHNSON HERNANDEZ | — |
| CHERYL LYNN JAEGER | — |
| MATHEW LAPINSKI | — |
| JASON BENJAMIN VAN PELT | — |
| STEPHEN THOMAS VOLJAVEC New | Legislative Director, Rep. Vern Buchanan; Legislative Assistant, Senator Marsha Blackburn |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.